Business Context and Reporting Period
This Form 8-K, filed on July 25, 2022, by Crane Co. (NYSE: CR), reports the results of operations for the quarter ended June 30, 2022. The filing primarily details the Company's ongoing exposure to asbestos-related litigation and provides an update on the estimated liability and insurance recoveries associated with these claims.
Key Financial Metrics: Asbestos Litigation
The filing focuses on costs and liabilities related to asbestos tort claims rather than general operating metrics like revenue or profit, which are referenced in a separate press release (Exhibit 99.1).
- Asbestos Liability: The total estimated liability for pending and future claims through 2059 was $580 million as of June 30, 2022, down from $612 million as of December 31, 2021.
- Current Portion: The current portion of the liability, representing costs expected to be paid within the next twelve months, is $62.3 million.
- Insurance Asset: The estimated probable insurance reimbursement asset was $65 million as of June 30, 2022, compared to $74 million as of December 31, 2021.
- Costs Incurred (Six Months Ended June 30, 2022): Total gross settlement and defense costs incurred were $28.5 million ($23.1 million for settlements/indemnity and $5.4 million for defense).
- Cash Payments (Six Months Ended June 30, 2022): Total pre-tax cash payments, net of insurance receipts, were $23.5 million.
- Pending Claims: There were 30,099 pending claims as of June 30, 2022. Approximately 18,000 of these are pending in New York, with roughly 16,000 being inactive non-malignancy claims filed over 15 years ago.
Material Changes Versus Prior Period
- Liability Reduction: The total asbestos liability decreased by $32 million from the prior year-end ($612 million to $580 million), primarily due to cash payments made for settled claims and defense costs.
- Cost Increases: Gross costs incurred for the six months ended June 30, 2022 ($28.5 million) increased compared to the same period in 2021 ($21.3 million). Specifically, settlement/indemnity costs rose from $13.9 million to $23.1 million.
- Cash Flow Impact: Net pre-tax cash payments increased to $23.5 million for the six months ended June 30, 2022, from $20.2 million in the prior year period.
- Claim Activity: New claims filed in the three months ended June 30, 2022, were 646, a decrease from 772 in the same period in 2021. However, settlements increased significantly to 347 from 176 in the prior year quarter.
Outlook, Risks, and Management Commentary
Management determined that no change to the asbestos liability estimate was warranted for the period ended June 30, 2022, as actual experience with mesothelioma claims generally approximated the assumptions in the liability model. The liability estimate extends through 2059, though cash payments are expected to continue beyond that date due to the lag between filing and resolution.
Key Risks and Uncertainties:
- Estimation Variables: The liability estimate is subject to significant uncertainty regarding the number of new claims, average settlement costs (particularly for mesothelioma), dismissal rates, and defense costs.
- Legal and Legislative Factors: Future changes in case law, appellate rulings, or federal legislation could materially alter the liability estimate.
- Insurance Recovery: The estimated insurance reimbursement asset is based on the financial viability of insurers and the interpretation of policy terms. Actual reimbursements may vary from estimates.
- Non-Discounted Liability: The recorded liability is not discounted to present value due to the inability to reliably forecast payment timing.
Investor Verification Checklist
- Verify the full quarterly financial results (revenue, net income, cash flow) in the press release and data supplement referenced as Exhibit 99.1, as this 8-K focuses solely on litigation.
- Monitor the ratio of new claims filed versus claims dismissed to assess the trajectory of the 30,099 pending claims.
- Review the status of the two remaining solvent excess insurers with whom the Company has not yet concluded settlements.
- Track the actual cash payments against the $62.3 million current liability portion to validate the timing assumptions of the actuarial model.
- Assess the impact of the "Dummitt v. Crane Co." precedent on future settlement values in New York jurisdictions.